➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
McKesson
Mallinckrodt
Johnson and Johnson

Last Updated: April 14, 2021

DrugPatentWatch Database Preview

VILTOLARSEN - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for viltolarsen and what is the scope of patent protection?

Viltolarsen is the generic ingredient in one branded drug marketed by Nippon Shinyaku and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Viltolarsen has forty-three patent family members in twenty countries.

Summary for VILTOLARSEN
International Patents:43
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Clinical Trials: 3
What excipients (inactive ingredients) are in VILTOLARSEN?VILTOLARSEN excipients list
DailyMed Link:VILTOLARSEN at DailyMed
Recent Clinical Trials for VILTOLARSEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
NS Pharma, Inc.Phase 4
Nippon Shinyaku Co., Ltd.Phase 3
NS Pharma, Inc.Phase 3

See all VILTOLARSEN clinical trials

US Patents and Regulatory Information for VILTOLARSEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nippon Shinyaku VILTEPSO viltolarsen SOLUTION;INTRAVENOUS 212154-001 Aug 12, 2020 RX Yes Yes   Start Trial   Start Trial   Start Trial
Nippon Shinyaku VILTEPSO viltolarsen SOLUTION;INTRAVENOUS 212154-001 Aug 12, 2020 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
Harvard Business School
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.